Feldspar Pb isotopes have been widely used to trace magmatic formation and evolution processes.However,it remains unclear whether post-magmatic thermal events can affect feldspar Pb isotopic ratios.Here,the in situ Pb...Feldspar Pb isotopes have been widely used to trace magmatic formation and evolution processes.However,it remains unclear whether post-magmatic thermal events can affect feldspar Pb isotopic ratios.Here,the in situ Pb isotopic composition of feldspar hosted in granitic rocks(thirteen Archean and one Paleoproterozoic)from the northern Kongling terrane,Yangtze Craton,South China,is analyzed.The samples reveal a substantial variation in their Pb isotopic composition,spanning the gap between the 1.9 Ga and present-day geochrons,which indicates extensive resetting by later tectonothermal events.This resetting was interpreted to have likely resulted from Paleoproterozoic and Neoproterozoic tectonothermal events related to the assembly and breakup of the Columbia and Rodinia supercontinents.These results suggest that Pb isotopes should be used cautiously when tracing magma sources and petrogenesis in magmatic rocks that have experienced post-magmatic reworking.However,the in situ Pb isotopic composition of feldspar in ancient granitoids may also potentially be used to reveal later tectonothermal events.The extensive resetting of the Pb isotopic composition in feldspar by regional thermal events may also provide new insights into our understanding of the Pb isotope paradox.展开更多
据世界卫生组织估计,戊型肝炎病毒(hepatitis E virus,HEV)每年全球约有2000万例的新发感染,可能导致超过300万例急性肝炎。我国是戊型病毒性肝炎(戊肝)高流行区,近年来戊肝发病人数已超过甲型病毒性肝炎(甲肝)。戊肝发病率从2010年的1....据世界卫生组织估计,戊型肝炎病毒(hepatitis E virus,HEV)每年全球约有2000万例的新发感染,可能导致超过300万例急性肝炎。我国是戊型病毒性肝炎(戊肝)高流行区,近年来戊肝发病人数已超过甲型病毒性肝炎(甲肝)。戊肝发病率从2010年的1.77/10万上升至2019年的2.02/10万。我国HEV感染途径主要为食源性感染。慢性HEV感染是指患者感染HEV后,血或粪便中病毒核酸持续阳性3个月以上,其多发生于免疫低下人群,并可能导致患者出现肝纤维化和肝硬化的快速进展。我国以HEV 4型感染为主,因此我国慢性戊肝患者感染的病毒也主要为HEV 4型。HEV感染诊断主要依据特异性HEV抗体或病原学指标。HEV感染筛查应着重关注基础肝病患者、育龄期妇女和老年人及免疫缺陷患者(如器官移植患者、血液肿瘤患者、HIV感染者)等。戊肝诊治中仍然存在很多问题,包括慢性戊肝患者肝纤维化快速进展的危险因素尚未明确;老年男性和孕妇感染HEV后易出现重症的机制有待研究;抗HEV药物筛选多为体外细胞模型的结果,治疗药物仍处于临床前研究阶段。今后应聚焦戊肝的发病机制研究,推动基础研究和临床研究的交叉、融合与转化,为慢性戊肝诊治的药物治疗提供更多有效方案。展开更多
基金supported by the Key Laboratory of Gold Mineralization Processes and Resource Utilization,MNRShandong Provincial Key Laboratory of Metallogenic Geological Process and Resource Utilization(Grant No.KFKT202103)National Natural Science Foundation of China(Grant No.41876037)。
文摘Feldspar Pb isotopes have been widely used to trace magmatic formation and evolution processes.However,it remains unclear whether post-magmatic thermal events can affect feldspar Pb isotopic ratios.Here,the in situ Pb isotopic composition of feldspar hosted in granitic rocks(thirteen Archean and one Paleoproterozoic)from the northern Kongling terrane,Yangtze Craton,South China,is analyzed.The samples reveal a substantial variation in their Pb isotopic composition,spanning the gap between the 1.9 Ga and present-day geochrons,which indicates extensive resetting by later tectonothermal events.This resetting was interpreted to have likely resulted from Paleoproterozoic and Neoproterozoic tectonothermal events related to the assembly and breakup of the Columbia and Rodinia supercontinents.These results suggest that Pb isotopes should be used cautiously when tracing magma sources and petrogenesis in magmatic rocks that have experienced post-magmatic reworking.However,the in situ Pb isotopic composition of feldspar in ancient granitoids may also potentially be used to reveal later tectonothermal events.The extensive resetting of the Pb isotopic composition in feldspar by regional thermal events may also provide new insights into our understanding of the Pb isotope paradox.
文摘据世界卫生组织估计,戊型肝炎病毒(hepatitis E virus,HEV)每年全球约有2000万例的新发感染,可能导致超过300万例急性肝炎。我国是戊型病毒性肝炎(戊肝)高流行区,近年来戊肝发病人数已超过甲型病毒性肝炎(甲肝)。戊肝发病率从2010年的1.77/10万上升至2019年的2.02/10万。我国HEV感染途径主要为食源性感染。慢性HEV感染是指患者感染HEV后,血或粪便中病毒核酸持续阳性3个月以上,其多发生于免疫低下人群,并可能导致患者出现肝纤维化和肝硬化的快速进展。我国以HEV 4型感染为主,因此我国慢性戊肝患者感染的病毒也主要为HEV 4型。HEV感染诊断主要依据特异性HEV抗体或病原学指标。HEV感染筛查应着重关注基础肝病患者、育龄期妇女和老年人及免疫缺陷患者(如器官移植患者、血液肿瘤患者、HIV感染者)等。戊肝诊治中仍然存在很多问题,包括慢性戊肝患者肝纤维化快速进展的危险因素尚未明确;老年男性和孕妇感染HEV后易出现重症的机制有待研究;抗HEV药物筛选多为体外细胞模型的结果,治疗药物仍处于临床前研究阶段。今后应聚焦戊肝的发病机制研究,推动基础研究和临床研究的交叉、融合与转化,为慢性戊肝诊治的药物治疗提供更多有效方案。
